Literature DB >> 33670699

The Role of the Pathologist in the Next-Generation Era of Tumor Molecular Characterization.

Valentina Angerilli1, Francesca Galuppini1, Fabio Pagni2, Nicola Fusco3,4, Umberto Malapelle5, Matteo Fassan1.   

Abstract

Current pathology practice is being shaped by the increasing complexity of modern medicine, in particular of precision oncology, and major technological advances. In the "next-generation technologies era", the pathologist has become the person responsible for the integration and interpretation of morphologic and molecular information and for the delivery of critical answers to diagnostic, prognostic and predictive queries, acquiring a prominent position in the molecular tumor boards.

Entities:  

Keywords:  molecular pathology; next generation technologies; oncology; predictive biomarkers

Year:  2021        PMID： 33670699     DOI： 10.3390/diagnostics11020339

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN： 2075-4418


  12 in total

Review 1.  Microsatellite Instable Colorectal Adenocarcinoma Diagnostics: The Advent of Liquid Biopsy Approaches.

Authors:  Carlotta Ceccon; Valentina Angerilli; Cosimo Rasola; Letizia Procaccio; Marianna Sabbadin; Francesca Bergamo; Umberto Malapelle; Sara Lonardi; Matteo Fassan
Journal:  Front Oncol       Date:  2022-06-28       Impact factor: 5.738

2.  Biomarker characterization in endometrial cancer in Italy: first survey data analysis.

Authors:  Gian Franco Zannoni; Angela Santoro; Nicoletta D'Alessandris; Giulia Scaglione; Frediano Inzani; Giuseppe Angelico; Emma Bragantini; Alessia Piermattei; Federica Cianfrini; Brigitte Bisaro; Matteo Fassan
Journal:  Pathologica       Date:  2022-06

Review 3.  FFPE-Based NGS Approaches into Clinical Practice: The Limits of Glory from a Pathologist Viewpoint.

Authors:  Filippo Cappello; Valentina Angerilli; Giada Munari; Carlotta Ceccon; Marianna Sabbadin; Fabio Pagni; Nicola Fusco; Umberto Malapelle; Matteo Fassan
Journal:  J Pers Med       Date:  2022-05-05

Review 4.  Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists.

Authors:  Nicola Fusco; Moira Ragazzi; Elham Sajjadi; Konstantinos Venetis; Roberto Piciotti; Stefania Morganti; Giacomo Santandrea; Giuseppe Nicolò Fanelli; Luca Despini; Marco Invernizzi; Bruna Cerbelli; Cristian Scatena; Carmen Criscitiello
Journal:  Histol Histopathol       Date:  2021-09-29       Impact factor: 2.303

5.  Pathological examination of breast cancer samples before and after neoadjuvant therapy: recommendations from the Italian Group for the Study of Breast Pathology - Italian Society of Pathology (GIPaM-SIAPeC).

Authors:  Nicola Fusco; Antonio Rizzo; Leopoldo Costarelli; Alfredo Santinelli; Bruna Cerbelli; Cristian Scatena; Ettore Macrì; Francesca Pietribiasi; Giulia d'Amati; Anna Sapino; Isabella Castellano
Journal:  Pathologica       Date:  2022-04-13

Review 6.  Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization.

Authors:  Elham Sajjadi; Konstantinos Venetis; Roberto Piciotti; Marco Invernizzi; Elena Guerini-Rocco; Svasti Haricharan; Nicola Fusco
Journal:  Cancer Cell Int       Date:  2021-05-17       Impact factor: 5.722

7.  Commentary: Mismatch Repair Deficiency and Microsatellite Instability in Triple-Negative Breast Cancer: A Retrospective Study of 440 Patients.

Authors:  Konstantinos Venetis; Nicola Fusco; Elham Sajjadi
Journal:  Front Oncol       Date:  2021-09-29       Impact factor: 6.244

Review 8.  HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer.

Authors:  Konstantinos Venetis; Edoardo Crimini; Elham Sajjadi; Chiara Corti; Elena Guerini-Rocco; Giuseppe Viale; Giuseppe Curigliano; Carmen Criscitiello; Nicola Fusco
Journal:  Front Mol Biosci       Date:  2022-03-15

9.  The Third Joint Meeting on Lung Cancer of the FHU OncoAge (University Côte d'Azur, Nice, France) and the University of Texas MD Anderson Cancer Center (Houston, TX, USA). Understanding New Therapeutic Options and Promising Predictive Biomarkers for Lung Cancer Patients.

Authors:  Paul Hofman; George A Calin; Sandurai A Mani; Christophe Bontoux; Marius Ilié; Ignacio I Wistuba
Journal:  Cancers (Basel)       Date:  2022-09-04       Impact factor: 6.575

10.  Special Issue: Molecular Biomarkers in Solid Tumors.

Authors:  Nicola Fusco; Caterina Marchiò; Michele Ghidini; Cristian Scatena
Journal:  Genes (Basel)       Date:  2021-06-28       Impact factor: 4.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.